Survival of Patients with Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Study
Top Cited Papers
Open Access
- 15 November 2014
- journal article
- research article
- Published by Elsevier BV in Transplantation and Cellular Therapy
- Vol. 21 (3), 454-459
- https://doi.org/10.1016/j.bbmt.2014.11.007
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (U24-CA076518)
- National Heart, Lung, and Blood Institute
- National Institute of Allergy and Infectious Diseases
- NHLBI (5U10HL069294)
- NCI
- Office of Naval Research (N00014-12-1-0142, N00014-13-1-0039)
- Actinium Pharmaceuticals
- Allos Therapeutics
- Amgen
This publication has 23 references indexed in Scilit:
- National Cancer Institute’s First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Summary and Recommendations from the Organizing CommitteeTransplantation and Cellular Therapy, 2011
- NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell TransplantationTransplantation and Cellular Therapy, 2010
- Relapse after Allogeneic Hematopoietic Cell TherapyTransplantation and Cellular Therapy, 2010
- Defining the Intensity of Conditioning Regimens: Working DefinitionsTransplantation and Cellular Therapy, 2009
- Reduced-Intensity Conditioning Regimen Workshop: Defining the Dose Spectrum. Report of a Workshop Convened by the Center for International Blood and Marrow Transplant ResearchTransplantation and Cellular Therapy, 2009
- Classification of HLA-Matching for Retrospective Analysis of Unrelated Donor Transplantation: Revised Definitions to Predict SurvivalTransplantation and Cellular Therapy, 2008
- Donor leukocyte infusions for the treatment of relapsed acute leukemia after allogeneic stem cell transplantationBone Marrow Transplantation, 2007
- Donor Lymphocyte Infusion in the Treatment of First Hematological Relapse After Allogeneic Stem-Cell Transplantation in Adults With Acute Myeloid Leukemia: A Retrospective Risk Factors Analysis and Comparison With Other Strategies by the EBMT Acute Leukemia Working PartyJournal of Clinical Oncology, 2007
- Treatment of Relapsed Acute Leukemia after Allogeneic Transplantation: A Single Center ExperienceTransplantation and Cellular Therapy, 2007
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958